Skip to main content
Press release February 12, 2026

Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Cytek Biosciences, Inc. (CTKB)

FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026.
View original release